Zhejiang Shengda Bio-Pharm Co., Ltd.
SHH: 603079.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Bin Zhou
- Employees
- 1,032
- Headquarters
- Tiantai, China
- IPO year
- 2017
- Market cap
- CN¥3.0B
- Website
- https://www.sd-pharm.com
Loading 603079…
Loading profile data…Frequently asked questions about 603079
What does Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) do?
Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives worldwide. The company offers vitamins, such as biotin and folic acid, etc.; biological fresh-keeping agents, including nisin and natamycin; and intermediate APIs. It also produces natural food preservatives. The company is...
Where does 603079.SS trade?
Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) trades on the Shanghai Stock Exchange.
What sector is 603079.SS in?
Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Shengda Bio-Pharm Co., Ltd.?
Bin Zhou is the chief executive officer of Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS).
Where is Zhejiang Shengda Bio-Pharm Co., Ltd. headquartered?
Zhejiang Shengda Bio-Pharm Co., Ltd. is headquartered in China.
Does 603079.SS pay a dividend?
Yes — Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) paid a trailing twelve-month dividend of CNY 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603079.SS go public?
Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) completed its initial public offering in 2017.